Novavax Vaccine Trial Gets 30,000 Volunteers

SMS
Novavax Vaccine Trial Gets 30,000 Volunteers
Maryland-based biotech company says it is in late-stage study of coronavirus vaccine.
SHOW TRANSCRIPT

Novavax has about 30,000 volunteers from the U.S. and Mexico for its COVID vaccine candidate.

The company is in a late stage study and last month said the vaccine was nearly 90 percent effective against the variant found in the U.K..

Novavax's candidate is a two-shot vaccine.